Publications by authors named "P S Walmod"

Claim this Profile
A
An injectable 2.5% cross-linked polyacrylamide hydrogel (2.5 iPAAG) demonstrates no neurotoxicity in human induced pluripotent stem cells-derived iCell GlutaNeurons.
Peter S Walmod, Philip Kusk, Nina Jøhnk, Ieva Ankorina-Stark, Anthony Essex

Front Toxicol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCAM2 Fibronectin type-III domains form a rigid structure that binds and activates the Fibroblast Growth Factor Receptor.
Kim Krighaar Rasmussen, Maria Hansen Falkesgaard, Malene Winther, Nikolaj Kulahin Roed, Christine Louise Quistgaard, Peter Schledermann Walmod

Sci Rep· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression, refolding and spectroscopic characterization of fibronectin type III (FnIII)-homology domains derived from human fibronectin leucine rich transmembrane protein (FLRT)-1, -2, and -3.
Lila Yang, Maria Hansen Falkesgaard, Peter Waaben Thulstrup, Peter Schledermann Walmod, Leila Lo Leggio

PeerJ· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epobis is a Nonerythropoietic and Neuroprotective Agonist of the Erythropoietin Receptor with Anti-Inflammatory and Memory Enhancing Effects.
Oksana Dmytriyeva, Stanislava Pankratova, Irina Korshunova, Peter S Walmod

Mediators Inflamm· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting of ECM molecules and their metabolizing enzymes and receptors for the treatment of CNS diseases.
Vladimir Berezin, Peter S Walmod, Mikhail Filippov, Alexander Dityatev

Prog Brain Res· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis